Company fined 9.1 billion yuan in rabies vaccine scandal
Share - WeChat


Changchun Changsheng Bio-tech Co, a company in Northeast China's Jilin province that fabricated production records for freeze-dried rabies vaccines for human use and was linked to a substandard DTaP vaccine for infants in July, received a fine totaling 9.1 billion yuan ($1.32 billion) on Tuesday, according to the decision of the State Drug Administration and the Jilin Food and Drug Administration.
Fourteen company executives and others who bear direct responsibility were banned from participating in drug production and related activities in the future, according to the decision. Those suspected of breaking the law will be given criminal punishments according to the law, it said.
- Taiyuan officials draw lessons from April 30 explosion
- Xi's diplomacy injects certainty, stability into turbulent world
- Vibrant snapshots of China during Labor Day holiday
- Revised infectious disease law strengthens public health system
- Port in Macao sets new records on 1st day of May Day holiday
- SW China's Yunnan province holds intl twins festival